Loading...
Teva Pharmaceutical Industries Limited
TEVA•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$16.30
$0.25(1.53%)
Teva Pharmaceutical Industries Limited (TEVA) AI-Powered Stock Analysis
See how Teva Pharmaceutical Industries Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerTeva Pharmaceutical Industries Limited (TEVA) Stock Overall Grade
Teva Pharmaceutical Industries Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Teva Pharmaceutical Industries Limited's overall stock rating.
Forecast
BScore
63/100Financial Growth
BScore
60/100Fundamental Growth
C+Score
56/100Key Ratios
C+Score
57/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
75/100Teva Pharmaceutical Industries Limited (TEVA) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 63/100 (B), reflecting high confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (56/100, C+) highlight its stability, while Key Ratios (57/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Teva Pharmaceutical Industries Limited stock grade, including financials, comparisons, and forecasts.